The use of MRI apparent diffusion coefficient (ADC) in monitoring the development of brain infarction

BMC Medical Imaging

Research Article

Liang Sheng¹  Jian-Jun Yuan¹  Xian-Wu Xia¹  Jian-Min Shen¹  Wu-Gen Kang¹ 

[1] Department of Medical imaging, Taizhou municipal hospital, Taizhou Medical College, 318000, Taizhou, P.R. China;

关键词: Apparent Diffusion Coefficient;    Diffusion Weighted Imaging;    Brain Infarction;    Acute Case;    Average Apparent Diffusion Coefficient;   

DOI  :  10.1186/1471-2342-11-2

 received in 2010-07-28, accepted in 2011-01-06,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundTo study the rules that apparent diffusion coefficient (ADC) changes with time and space in cerebral infarction, and to provide the evidence in defining the infarction stages.Methods117 work-ups in 98 patients with cerebral infarction (12 hyperacute, 43 acute, 29 subacute, 10 steady, and 23 chronic infarctions) were imaged with both conventional MRI and diffusion weighted imaging. The average ADC values, the relative ADC (rADC) values, and the ADC values or rADC values from the center to the periphery of the lesion were calculated.ResultsThe average ADC values and the rADC values of hyperacute and acute infarction lesion depressed obviously. rADC values in hyperacute and acute stage was minimized, and increased progressively as time passed and appeared as "pseudonormal" values in approximately 8 to 14 days. Thereafter, rADC values became greater than normal in chronic stage. There was positive correlation between rADC values and time (P < 0.01). The ADC values and the rADC values in hyperacute and acute lesions had gradient signs that these lesions increased from the center to the periphery. The ADC values and the rADC values in subacute lesions had adverse gradient signs that these lesions decreased from the center to the periphery.ConclusionThe ADC values of infarction lesions have evolution rules with time and space. The evolution rules with time and those in space can be helpful to decide the clinical stage, and to provide the evidence in guiding the treatment or judging the prognosis in infarction.

【 授权许可】

CC BY   
© Shen et al; licensee BioMed Central Ltd. 2011